Training Cognition With Neurofeedback After Stroke
Condition(s) studied
Investigational drug(s) / intervention(s)
Cognitive remediation therapy: Cognitive remediation therapy as treatment as usual
Neuropsychological assessment: Neuropsychological assessment to measure cognitive performances
Real-time functional MRI neurofeedack (rt-fMRI NF): Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction.
fMRI sessions: fMRI sessions but without receiving feedback
Study summary
Post-stroke cognitive impairment (PSCI) is a common source of invisible disability. The actual techniques of cognitive remediation have been reported to have only a small effect, justifying the need to foster research in this field. Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction, using rt-fMRI NF
Eligibility
Primary outcome measure(s)
- Differential CEN-DMN activity and imaging contrast between regulation and rest — Through study training completion, an average of 4 weeks
Change from baseline to each training session on the CEN-DMN activity during regulation compared with rest, in the experimental and control groups
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Bordeaux | Bordeaux | France | Recruiting |
More University Hospital, Bordeaux trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06852209 on ClinicalTrials.gov ↗ ← All trials in France